The global viral clearance service market size was valued at US$ 263.2 Mn in 2018 and is projected to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% during the forecast period. The report suggests that increased outsourcing of viral clearance testing studies, rise in focus on early clearance of virus in biologics, increased burden of regulatory requirements, rise in R&D expenditure, expansion of economies of the world, and increase in disposable income are likely to drive the viral clearance service market from 2019 to 2026. Introduction of several new target therapies into the market has necessitated the testing of target therapies, and this has created demand for viral clearance across the globe. The field of bio-similar products and biologics has also undergone rapid advancements in recent times, which has further fuelled the global viral clearance market. Rise in incidence of several infectious diseases has also propelled the global market.
The report analyzes and forecasts the viral clearance service market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of viral clearance service, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major viral clearance service companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of viral clearance service upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of viral clearance service and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global viral clearance service market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the viral clearance service market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of viral clearance service market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report profiles the major players operating in the global viral clearance service market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXi AppTec, Clean Cells, and Vironova Biosafety.
The global viral clearance service market has been segmented as follows:
Global Viral Clearance Service Market, by Application
Global Viral Clearance Service Market, by Method
Global Viral Clearance Service Market, by End-user
Global Viral Clearance Service Market, by Region
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary : Global Viral Clearance Service
3.1.Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Geography, 2017 and 2026
3.2. Global Viral Clearance Service Market Snapshot, 2017
3.3. Global Viral Clearance Service Market: Opportunity Map
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increased outsourcing of viral clearance testing studies
4.3.1.2. Rise in R&D expenditure
4.3.1.3. Rise in focus on early clearance of virus in biologics
4.3.1.4. Increased burden of regulatory requirements
4.3.1.5. Technological advancements
4.3.1.6. Growing economies of the world
4.3.2. Restraints
4.3.2.1. Reduction of preclinical outsourcing budget by some of the large pharma companies
4.3.2.2. High cost and complexity involved in the development and approval of biologics and biosimilars
4.3.3. Opportunities
4.4. Global Viral Clearance Service Market Analysis and Forecast, 2018–2026
4.4.1. Global Viral Clearance Service Market Value (US$ Mn) Forecast
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Regulatory Scenario by Region/globally
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. Key Market Trends
5.5. Competitive Landscape Analysis (based on strategic developments of players)
5.6. Future Prospects Assessment
6. Global Viral Clearance Service Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Viral Clearance Service Market Value Forecast, by Application, 2018–2026
6.3.1. Recombinant Proteins
6.3.2. Tissue and Blood Derived Products
6.3.3. Vaccines
6.3.4. Others
6.4. Global Viral Clearance Service Market Attractiveness, by Application
7. Global Viral Clearance Service Analysis and Forecast, by Method
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Viral Clearance Service Market Value Forecast, by Method, 2018–2026
7.3.1. Viral Removal
7.3.2. Viral Inactivation
7.3.2.1. Chemical
7.3.2.2. Radiation
7.3.2.3. Other
7.4. Global Viral Clearance Service Market Attractiveness, by Method
8. Global Viral Clearance Service Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Viral Clearance Service Market Value Forecast, by End-user, 2018–2026
8.3.1. Biopharmaceuticals
8.3.2. Contract Research Organizations
8.3.3. Academic Research Institutes
8.3.4. Other End-users
8.4. Global Viral Clearance Service Market Attractiveness by End-user
9. Global Viral Clearance Service Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Viral Clearance Service Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Viral Clearance Service Market Attractiveness, by Region
10. North America Viral Clearance Service Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Viral Clearance Service Market Value Forecast, by Application, 2018–2026
10.2.1. Recombinant Proteins
10.2.2. Tissue and Blood Derived Products
10.2.3. Vaccines
10.2.4. Others
10.3. North America Viral Clearance Service Market Value Forecast, by Method, 2018–2026
10.3.1. Viral Removal
10.3.2. Viral Inactivation
10.3.2.1. Chemical
10.3.2.2. Radiation
10.3.2.3. Other
10.4. North America Viral Clearance Service Market Value Forecast, by End-user, 2018–2026
10.4.1. Biopharmaceuticals
10.4.2. Contract Research Organizations
10.4.3. Academic Research Institutes
10.4.4. Other End-users
10.5. North America Viral Clearance Service Market Value Forecast, by Country, 2018–2026
10.5.1. U.S.
10.5.2. Canada
10.6. North America Viral Clearance Service Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By Method
10.6.3. By End-user
10.6.4. By Country
11. Europe Viral Clearance Service Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. Europe Viral Clearance Service Market Value Forecast, by Application, 2018–2026
11.2.1. Recombinant Proteins
11.2.2. Tissue and Blood Derived Products
11.2.3. Vaccines
11.2.4. Others
11.3. Europe Viral Clearance Service Market Value Forecast, by Method, 2018–2026
11.3.1. Viral Removal
11.3.2. Viral Inactivation
11.3.2.1. Chemical
11.3.2.2. Radiation
11.3.2.3. Other
11.4. Europe Viral Clearance Service Market Value Forecast, by End-user, 2018–2026
11.4.1. Biopharmaceuticals
11.4.2. Contract Research Organizations
11.4.3. Academic Research Institutes
11.4.4. Other End-users
11.5. Europe Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2018–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Viral Clearance Service Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By Method
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Viral Clearance Service Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Asia Pacific Viral Clearance Service Market Value Forecast, by Application, 2018–2026
12.2.1. Recombinant Proteins
12.2.2. Tissue and Blood Derived Products
12.2.3. Vaccines
12.2.4. Others
12.3. Asia Pacific Viral Clearance Service Market Value Forecast, by Method, 2018–2026
12.3.1. Viral Removal
12.3.2. Viral Inactivation
12.3.2.1. Chemical
12.3.2.2. Radiation
12.3.2.3. Other
12.4. Asia Pacific Viral Clearance Service Market Value Forecast, by End-user, 2018–2026
12.4.1. Biopharmaceuticals
12.4.2. Contract Research Organizations
12.4.3. Academic Research Institutes
12.4.4. Other End-users
12.5. Asia Pacific Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2018–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Viral Clearance Service Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By Method
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Viral Clearance Service Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Latin America Viral Clearance Service Market Value Forecast, by Application, 2018–2026
13.2.1. Recombinant Proteins
13.2.2. Tissue and Blood Derived Products
13.2.3. Vaccines
13.2.4. Others
13.3. Latin America Viral Clearance Service Market Value Forecast, by Method, 2018–2026
13.3.1. Viral Removal
13.3.2. Viral Inactivation
13.3.2.1. Chemical
13.3.2.2. Radiation
13.3.2.3. Other
13.4. Latin America Viral Clearance Service Market Value Forecast, by End-user, 2018–2026
13.4.1. Biopharmaceuticals
13.4.2. Contract Research Organizations
13.4.3. Academic Research Institutes
13.4.4. Other End-users
13.5. Latin America Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2018–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Viral Clearance Service Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By Method
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Viral Clearance Service Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Viral Clearance Service Market Value Forecast, by Application, 2018–2026
14.2.1. Recombinant Proteins
14.2.2. Tissue and Blood Derived Products
14.2.3. Vaccines
14.2.4. Others
14.3. Middle East & Africa Viral Clearance Service Market Value Forecast, by Method, 2018–2026
14.3.1. Viral Removal
14.3.2. Viral Inactivation
14.3.2.1. Chemical
14.3.2.2. Radiation
14.3.2.3. Other
14.4. Middle East & Africa Viral Clearance Service Market Value Forecast, by End-user, 2018–2026
14.4.1. Biopharmaceuticals
14.4.2. Contract Research Organizations
14.4.3. Academic Research Institutes
14.4.4. Other End-users
14.5. Middle East & Africa Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2018–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Viral Clearance Service Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By Method
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Viral Clearance Service Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Global Viral Clearance Service Market Share Analysis, by Company (2017)
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Texcell
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Company Financials
15.4.1.3. Growth Strategies
15.4.1.4. Recent Events
15.4.1.5. SWOT Analysis
15.4.2. Eurofins Scientific SE
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Company Financials
15.4.2.3. Growth Strategies
15.4.2.4. Recent Events
15.4.2.5. SWOT Analysis
15.4.3. Charles River Laboratories International, Inc.
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Company Financials
15.4.3.3. Growth Strategies
15.4.3.4. Recent Events
15.4.3.5. SWOT Analysis
15.4.4. Merck KGaA (BioReliance)
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Company Financials
15.4.4.3. Growth Strategies
15.4.4.4. Recent Events
15.4.4.5. SWOT Analysis
15.4.5. WuXi AppTec
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Company Financials
15.4.5.3. Growth Strategies
15.4.5.4. Recent Events
15.4.5.5. SWOT Analysis
15.4.6. Clean Cells
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Company Financials
15.4.6.3. Growth Strategies
15.4.6.4. Recent Events
15.4.6.5. SWOT Analysis
15.4.7. Vironova Biosafety
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Company Financials
15.4.7.3. Growth Strategies
15.4.7.4. Recent Events
15.4.7.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers